The Valley Desk

ArticleBiomedicinesPublished

Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Lankenau Institute for Medical Research, with Main Line Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Biomedicines
Published
Subject terms
Molecular dynamics simulation; bcl-2; Drug Repurposing; Acute Myeloid Leukemia (Aml); Polypharmacology; Structure-based Virtual Screening; Idh1 R132h; Admet Profiling; Lsd1 (Kdm1a); Multitarget Therapeutics
PubMed ID
41301700
PubMed Central ID
PMC12650541
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal